251 related articles for article (PubMed ID: 24921656)
21. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
Kremer-Tal S; Narla G; Chen Y; Hod E; DiFeo A; Yea S; Lee JS; Schwartz M; Thung SN; Fiel IM; Banck M; Zimran E; Thorgeirsson SS; Mazzaferro V; Bruix J; Martignetti JA; Llovet JM; Friedman SL
J Hepatol; 2007 Apr; 46(4):645-54. PubMed ID: 17196295
[TBL] [Abstract][Full Text] [Related]
22. Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.
Bechmann LP; Gastaldelli A; Vetter D; Patman GL; Pascoe L; Hannivoort RA; Lee UE; Fiel I; Muñoz U; Ciociaro D; Lee YM; Buzzigoli E; Miele L; Hui KY; Bugianesi E; Burt AD; Day CP; Mari A; Agius L; Walker M; Friedman SL; Reeves HL
Hepatology; 2012 Apr; 55(4):1083-93. PubMed ID: 22095588
[TBL] [Abstract][Full Text] [Related]
23. The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.
Hanoun N; Bureau C; Diab T; Gayet O; Dusetti N; Selves J; Vinel JP; Buscail L; Cordelier P; Torrisani J
J Hepatol; 2010 Nov; 53(5):880-8. PubMed ID: 20801538
[TBL] [Abstract][Full Text] [Related]
24. Frequent down-regulation and deletion of KLF6 in primary hepatocellular carcinoma.
Wang S; Kang L; Chen X; Zhou H
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):470-6. PubMed ID: 20714872
[TBL] [Abstract][Full Text] [Related]
25. Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury.
Ghiassi-Nejad Z; Hernandez-Gea V; Woodrell C; Lang UE; Dumic K; Kwong A; Friedman SL
Hepatology; 2013 Feb; 57(2):786-96. PubMed ID: 22961688
[TBL] [Abstract][Full Text] [Related]
26. [Effect of KLF6 and its splice variant KLF6V on proliferation and differentiation of human hepatocellular carcinoma HepG2 cells].
Pan XC; Chen Z; Ji F; Guo ZS; Chen M; Fu JJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):683-7. PubMed ID: 18822210
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma.
Tchirkov A; Sapin V; Marceau G; Chautard E; Narla G; Veronese L; Friedman S; Khalil T; Vago P; Kemeny JL; Verrelle P
Clin Chem Lab Med; 2010 Aug; 48(8):1167-70. PubMed ID: 20545576
[TBL] [Abstract][Full Text] [Related]
28. Roles of Krüppel-like factor 6 splice variant 1 in the development, diagnosis, and possible treatment strategies for non-small cell lung cancer.
Hu K; Ma C; Ma R; Zheng Q; Wang Y; Zhang N; Sun Z
Am J Cancer Res; 2022; 12(10):4468-4482. PubMed ID: 36381325
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.
Zhang X; Nie Y; Du Y; Cao J; Shen B; Li Y
Tumour Biol; 2012 Oct; 33(5):1589-97. PubMed ID: 22581522
[TBL] [Abstract][Full Text] [Related]
31. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
[TBL] [Abstract][Full Text] [Related]
32. Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35.
Shi J; Hu Z; Pabon K; Scotto KW
Mol Cell Biol; 2008 Jan; 28(2):883-95. PubMed ID: 18025108
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.
Botella LM; Sanz-Rodriguez F; Komi Y; Fernandez-L A; Varela E; Garrido-Martin EM; Narla G; Friedman SL; Kojima S
Biochem J; 2009 Apr; 419(2):485-95. PubMed ID: 19076057
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
35. Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.
Wang J; Wang X; Wang Y; Li S; Wang X
Cancer Biol Ther; 2019; 20(5):680-691. PubMed ID: 30590988
[TBL] [Abstract][Full Text] [Related]
36. The
Ri K; Kim C; Pak C; Ri P; Om H
Microrna; 2020; 9(1):64-69. PubMed ID: 30868974
[TBL] [Abstract][Full Text] [Related]
37. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
Ahronian LG; Zhu LJ; Chen YW; Chu HC; Klimstra DS; Lewis BC
Oncogene; 2016 Sep; 35(35):4653-62. PubMed ID: 26876204
[TBL] [Abstract][Full Text] [Related]
38. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease.
Miele L; Beale G; Patman G; Nobili V; Leathart J; Grieco A; Abate M; Friedman SL; Narla G; Bugianesi E; Day CP; Reeves HL
Gastroenterology; 2008 Jul; 135(1):282-291.e1. PubMed ID: 18515091
[TBL] [Abstract][Full Text] [Related]
39. KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model.
Difeo A; Huang F; Sangodkar J; Terzo EA; Leake D; Narla G; Martignetti JA
Cancer Res; 2009 Jun; 69(11):4733-41. PubMed ID: 19435908
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress modulates KLF6Full and its splice variants.
Urtasun R; Cubero FJ; Nieto N
Alcohol Clin Exp Res; 2012 Nov; 36(11):1851-62. PubMed ID: 22486562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
